United States- Report Ocean published a new report on the Spinal Fusion Devices Market. The study includes an in-depth analysis of regional trends and market growth in North America, Europe, Asia-Pacific, and Middle East Africa. This study report also examines the challenges that are negativel
Vertical shear pelvic ring injuries present a unique challenge due to their inherent vertical and rotational instability. Binders, sheets or external fixators may at times underestimate the severity of initial displacement or mask associated occult injuries. Preoperative CT is necessary for ad
There were 221 press releases posted in the last 24 hours and 194,307 in the last 365 days.
The Orthopedic Trauma Devices Market is expected to surge at a CAGR of around 8% from 2021 to 2031.
NEW YORK, UNITED STATES, June 15, 2022 /EINPresswire.com/ -- The Orthopedi
There were 221 press releases posted in the last 24 hours and 194,307 in the last 365 days.
The Orthopedic Trauma Devices Market is expected to surge at a CAGR of around 8% from 2021 to 2031.
NEW YORK, UNITED STATES, June 15, 2022 /EINPresswire.com/ -- The Orthopedi
When you think Garmin, a bathroom scale is probably not the first thing that comes to mind. But the tech company best known for its navigation systems(opens in a new tab) and smartwatches(opens in a new tab) does, in fact, make body weight scales (in addition to dog trackers(opens in a new t
ENGLEWOOD, Colo.--(BUSINESS WIRE )--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance to its Ci
ENGLEWOOD, Colo.--(BUSINESS WIRE )--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance to its Ci
Mechanical Integration, the first new method to secure implants to bone since the introduction of osseointegration in the 1970s, is designed to address implant instability in normal and compromised bone.
AUSTIN, Texas, Feb. 23, 2022 /PRNewswire/ — OsteoCentric Technologie
Permanent link to this press release:
Delete press release Edit press rele
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.